These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32993590)

  • 1. External validation of three atherosclerotic cardiovascular disease risk equations in rural areas of Xinjiang, China.
    Jiang Y; Ma R; Guo H; Zhang X; Wang X; Wang K; Hu Y; Keerman M; Yan Y; Ma J; Song Y; Zhang J; He J; Guo S
    BMC Public Health; 2020 Sep; 20(1):1471. PubMed ID: 32993590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Analysis of Three Atherosclerotic Cardiovascular Disease Risk Prediction Models in Individuals Aged 75 and Older.
    Wang Z; Yang X; Li L; Zhang X; Zhou W; Chen S
    Clin Interv Aging; 2024; 19():529-538. PubMed ID: 38525315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of the China-PAR risk prediction model for atherosclerotic cardiovascular disease in a rural northern Chinese population].
    Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Huang SP; Dou HD; Gao P; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):439-445. PubMed ID: 28628144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of atherosclerotic cardiovascular risk prediction models in a rural Northern Chinese population: Results from the Fangshan Cohort Study.
    Tang X; Zhang D; He L; Wu N; Si Y; Cao Y; Huang S; Li N; Li J; Dou H; Gao P; Hu Y
    Am Heart J; 2019 May; 211():34-44. PubMed ID: 30831332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Risk Prediction Models for Atherosclerotic Cardiovascular Disease in a Prospective Korean Community-Based Cohort.
    Bae JH; Moon MK; Oh S; Koo BK; Cho NH; Lee MK
    Diabetes Metab J; 2020 Jun; 44(3):458-469. PubMed ID: 31950769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Atherosclerotic Cardiovascular Risk Prediction Models in China: Results From the CHERRY Study.
    Liu X; Shen P; Zhang D; Sun Y; Chen Y; Liang J; Wu J; Zhang J; Lu P; Lin H; Tang X; Gao P
    JACC Asia; 2022 Feb; 2(1):33-43. PubMed ID: 36340248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the performance of machine learning and conventional models for predicting atherosclerotic cardiovascular disease in a general Chinese population.
    Fan Z; Du Z; Fu J; Zhou Y; Zhang P; Shi C; Sun Y
    BMC Med Inform Decis Mak; 2023 Jul; 23(1):134. PubMed ID: 37488520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China).
    Yang X; Li J; Hu D; Chen J; Li Y; Huang J; Liu X; Liu F; Cao J; Shen C; Yu L; Lu F; Wu X; Zhao L; Wu X; Gu D
    Circulation; 2016 Nov; 134(19):1430-1440. PubMed ID: 27682885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Framingham General Cardiovascular Risk Score and Pooled Cohort Equations in a Community-Based Population: A Prospective Cohort Study Analysis 2006-2017.
    Jian JZ; Tzeng IS; Hsieh CF; Huang HL; Chen CL; Liu KL
    Acta Cardiol Sin; 2023 Nov; 39(6):879-887. PubMed ID: 38022424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 10- and 15-year performance analysis of ESC/EAS and ACC/AHA cardiovascular risk scores in a Southern European cohort.
    Santos-Ferreira C; Baptista R; Oliveira-Santos M; Moura JP; Gonçalves L
    BMC Cardiovasc Disord; 2020 Jun; 20(1):301. PubMed ID: 32560700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of 10-year atherosclerotic cardiovascular disease risk among community residents in Shanghai, China - a comparative analysis of risk algorithms.
    Zhang Y; Zhao Q; Ng N; Wang W; Wang N; Qiu Y; Yu Y; Xiang Y; Cui S; Zhu M; Jiang Y; Zhao G
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):2058-2067. PubMed ID: 34090771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index.
    Khera R; Pandey A; Ayers CR; Carnethon MR; Greenland P; Ndumele CE; Nambi V; Seliger SL; Chaves PHM; Safford MM; Cushman M; Xanthakis V; Vasan RS; Mentz RJ; Correa A; Lloyd-Jones DM; Berry JD; de Lemos JA; Neeland IJ
    JAMA Netw Open; 2020 Oct; 3(10):e2023242. PubMed ID: 33119108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Replacing the Pooled Cohort Equation With Other Cardiovascular Disease Risk Scores on Atherosclerotic Cardiovascular Disease Risk Assessment (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
    Qureshi WT; Michos ED; Flueckiger P; Blaha M; Sandfort V; Herrington DM; Burke G; Yeboah J
    Am J Cardiol; 2016 Sep; 118(5):691-6. PubMed ID: 27445216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the prediction model of atherosclerotic cardiovascular disease in the rural Xinjiang population based on survival analysis.
    Qian X; Keerman M; Zhang X; Guo H; He J; Maimaitijiang R; Wang X; Ma J; Li Y; Ma R; Guo S
    BMC Public Health; 2023 Jun; 23(1):1041. PubMed ID: 37264356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the performance of three cardiovascular disease risk scores: the Estonian Biobank cohort study.
    Saar A; Läll K; Alver M; Marandi T; Ainla T; Eha J; Metspalu A; Fischer K
    J Epidemiol Community Health; 2019 Mar; 73(3):272-277. PubMed ID: 30635435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of the 10-year risk of atherosclerotic cardiovascular disease in the Korean population.
    Park S; Kim YG; Ann SH; Cho YR; Kim SJ; Han S; Park GM
    Epidemiol Health; 2023; 45():e2023052. PubMed ID: 37189276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of China-PAR and Framingham risk score in assessment of 10-year cardiovascular disease risk in Chinese hypertensive patients.
    Chen X; Tu Q; Wang D; Liu J; Qin Y; Zhang Y; Xiang Q
    Public Health; 2023 Jul; 220():127-134. PubMed ID: 37315498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.
    Albarqouni L; Doust JA; Magliano D; Barr EL; Shaw JE; Glasziou PP
    Med J Aust; 2019 Mar; 210(4):161-167. PubMed ID: 30656697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of the China-PAR stroke risk equations in a rural northern Chinese population].
    Tang X; Zhang DD; Liu XF; Liu QP; Cao Y; Li N; Huang SP; Dou HD; Gao P; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 52(3):444-450. PubMed ID: 32541976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perirenal fat thickness contributes to the estimated 10-year risk of cardiovascular disease and atherosclerotic cardiovascular disease in type 2 diabetes mellitus.
    Wang W; Lv FY; Tu M; Guo XL
    Front Endocrinol (Lausanne); 2024; 15():1434333. PubMed ID: 39040678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.